INMInMed Pharmaceuticals Inc.

Nasdaq inmedpharma.com


$ 0.27 $ 0.02 (8.16 %)    

Wednesday, 18-Sep-2024 15:31:22 EDT
QQQ $ 472.49 $ -2.05 (-0.43 %)
DIA $ 416.26 $ -1.07 (-0.26 %)
SPY $ 562.20 $ -1.67 (-0.3 %)
TLT $ 99.62 $ -1.25 (-1.24 %)
GLD $ 235.53 $ -1.83 (-0.77 %)
$ 0.2783
$ 0.27
$ 0.25 x 1,000
-- x --
$ 0.27 - $ 0.28
$ 0.12 - $ 2.08
647,807
na
1.69M
$ 1.66
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-13-2024 03-31-2024 10-Q
2 02-13-2024 12-31-2023 10-Q
3 11-13-2023 09-30-2023 10-Q
4 09-29-2023 06-30-2023 10-K
5 05-15-2023 03-31-2023 10-Q
6 02-17-2023 12-31-2022 10-Q
7 11-14-2022 09-30-2022 10-Q
8 09-23-2022 06-30-2022 10-K
9 05-13-2022 03-31-2022 10-Q
10 02-14-2022 12-31-2021 10-Q
11 11-10-2021 09-30-2021 10-Q
12 09-24-2021 06-30-2021 10-K
13 05-13-2021 03-31-2021 10-Q
14 02-11-2021 12-31-2020 10-Q
15 12-17-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 shares-of-inmed-pharmaceuticals-seeing-increased-volume-after-gene-online-article-circulating-inmed-pharmaceuticals-positive-market-response-to-cannabinoid-analog-inm-901-for-alzheimers-treatment

https://www.geneonline.com/inmed-pharmaceuticals-positive-market-response-to-cannabinoid-analog-inm-901-for-alzheimers-treatment/

 inmed-pharmaceuticals-advances-oral-candidate-for-alzheimers-disease-stock-surges-on-tuesday

InMed Pharmaceuticals advances INM-901 as an oral treatment for Alzheimer's. Preclinical studies show the small molecule dr...

 inmed-pharmaceuticals-has-received-a-notice-of-allowance-for-its-us-patent-application-16644484-titled-metabolic-engineering-of-e-coli-for-the-biosynthesis-of-cannabinoid-products

https://patentcenter.uspto.gov/applications/16644484/ifw/docs

 inmed-pharmaceuticals--provides-update-on-inm-089-in-the-treatment-of-dry-age-related-macular-degeneration-small-molecule-drug-acting-as-a-preferential-signaling-ligand-for-cb1cb2

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration   ● Small molecule drug acting as a...

 inmed-pharmaceuticals-has-received-a-notice-of-allowance-for-its-us-patent-application-16098324-titled-use-of-topical-formulations-of-cannabinoids-in-the-treatment-of-epidermolysis-bullosa-and-related-connective-tissue-disorders

https://patentcenter.uspto.gov/applications/16098324/ifw/docs

 inmed-pharmaceuticals-and-2-other-penny-stocks-insiders-are-buying

The Dow Jones index closed higher by over 450 points on Thursday. When insiders purchase or sell shares, it indicates their con...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION